Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Neurostimulation for chronic pain therapy

Dear Sir or Madam,

Neurostimulators are playing an increasingly important role in the treatment of chronic neuropathic pain by using targeted electrical impulses to modulate pain signals. Medtronics Inceptiv™ is a neurostimulator currently in use in the EU and Japan. The closed-loop technology enables automatic adjustment of the stimulation to ensure optimal pain relief. In our use case, learn more about how neurosurgical specialists and pain therapists surgically implant and program the neurostimulator.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents
Use case: Inceptiv™ fighting chronic neuropathic pain
Newsletter Service

Neurostimulation: Inceptiv™ fighting chronic neuropathic pain

Use case – MED TECH & DEVICES
Image: Elderly man with glasses and light green top holds his hand to his aching neck
Neurostimulators play an important role in the treatment of chronic pain conditions. They use targeted electrical impulses to modulate pain signals. The Inceptiv™ neurostimulator from Medtronic is an example of a treatment solution for chronic neuropathic pain. It can offer sufferers a significant improvement in their quality of life.
Click here for the use case
Neurostimulation: Inceptiv™ fighting chronic neuropathic pain
Image: Banner with the text: Discover the world of MED Tech & DEVICES here; Copyright: Messe Düsseldorf
To top

New diagnostic software improves analysis of kidney diseases

News

DIGITAL HEALTH
Researchers at the University Hospital Bonn, in collaboration with the University of Bonn, have developed a computer method to determine whether protein excretion in urine is caused by a few severely damaged or many slightly damaged kidney filters. The innovative findings were published in the journal Kidney International.
read more
To top

Cardiac medicine: minimally invasive replacement of any heart valve

News

MED TECH & DEVICES
Hannover Medical School (MHH) is presenting a decisive advancement in cardiology: the minimally invasive replacement of the tricuspid valve using a new catheter system, a significant expansion of treatment options for heart valve defects.
read more
To top

Insights into the development of metastases with miniature laboratories

News

LAB & DIAGNOSTICS
New developments at the Fraunhofer Institute for Material and Beam Technology IWS and partners enable improved research possibilities for cancer therapy using microphysiological systems.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.